These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9367545

  • 21. Human CD4+ effector T cells mediate indirect interleukin-12- and interferon-gamma-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient mice.
    Egilmez NK, Hess SD, Chen FA, Takita H, Conway TF, Bankert RB.
    Cancer Res; 2002 May 01; 62(9):2611-7. PubMed ID: 11980657
    [Abstract] [Full Text] [Related]

  • 22. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
    Porrata LF, Inwards DJ, Lacy MQ, Markovic SN.
    Bone Marrow Transplant; 2001 Oct 01; 28(7):673-80. PubMed ID: 11704790
    [Abstract] [Full Text] [Related]

  • 23. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY.
    J Soc Gynecol Investig; 1995 Oct 01; 2(6):762-71. PubMed ID: 9420887
    [Abstract] [Full Text] [Related]

  • 24. Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms.
    Takeuchi E, Yanagawa H, Yano S, Haku T, Sone S.
    Jpn J Cancer Res; 1996 Dec 01; 87(12):1251-8. PubMed ID: 9045960
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M, Sakuta K, Noguchi A, Ariyoshi N, Sato K, Sato S, Sato K, Hosoi A, Nakajima J, Yoshida Y, Shiraishi K, Nakagawa K, Kakimi K.
    Cytotherapy; 2008 Dec 01; 10(8):842-56. PubMed ID: 19016372
    [Abstract] [Full Text] [Related]

  • 28. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production.
    O'Hara RJ, Greenman J, MacDonald AW, Gaskell KM, Topping KP, Duthie GS, Kerin MJ, Lee PW, Monson JR.
    Clin Cancer Res; 1998 Aug 01; 4(8):1943-8. PubMed ID: 9717823
    [Abstract] [Full Text] [Related]

  • 29. The influence of interleukin-10 and interleukin-18 on interferon-gamma production by peritoneal exudate cells in patients with gastric carcinoma.
    Majima T, Ichikura T, Seki S, Takayama E, Matsumoto A, Kawabata T, Chochi K, Hiraide H, Mochizuki H.
    Anticancer Res; 2002 Aug 01; 22(2B):1193-9. PubMed ID: 12168924
    [Abstract] [Full Text] [Related]

  • 30. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H, Seki S, Habu Y, Ohkawa T, Takeshita S, Hiraide H, Sekine I.
    Hepatology; 1999 Aug 01; 30(2):430-6. PubMed ID: 10421651
    [Abstract] [Full Text] [Related]

  • 31. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X, Wilbanks GD, Devaja O, Ruperelia V, Raju KS.
    Gynecol Oncol; 1999 Nov 01; 75(2):198-210. PubMed ID: 10525372
    [Abstract] [Full Text] [Related]

  • 32. Generation of killer activity by interleukin-12 of mononuclear cells in malignant pleural effusions due to lung cancer.
    Hiramatsu K, Yanagawa H, Haku T, Sone S.
    Cancer Immunol Immunother; 1998 Mar 01; 46(1):1-6. PubMed ID: 9520285
    [Abstract] [Full Text] [Related]

  • 33. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W, Nishioka Y, Ozaki S, Jalili A, Verma VK, Hanibuchi M, Abe S, Minakuchi K, Matsumoto T, Sone S.
    Lung Cancer; 2009 Jan 01; 63(1):23-31. PubMed ID: 18524412
    [Abstract] [Full Text] [Related]

  • 34. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K, Iwagaki H, Yoshino T, Morimoto Y, Kohka H, Kodama M, Nishibori M, Akagi T, Tanaka N.
    Anticancer Res; 2001 Jan 01; 21(5):3285-93. PubMed ID: 11848485
    [Abstract] [Full Text] [Related]

  • 35. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Jan 01; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 36. The effectors of killer activity induced by interferon-alpha and gamma in peripheral blood mononuclear cells.
    Sakaguchi M, Kubota S, Nishikido M, Taniguchi K, Inuzuka S, Saito Y, Kanetake H, Koga S.
    Int J Mol Med; 2002 Sep 01; 10(3):317-20. PubMed ID: 12165807
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.